Replies to post #58802 on Biotech Values

[DewDiligence]

Re: Pre-dosing with drug to screen patients for trials

Would you prefer the word strain rather than mutation? In any case, the maraviroc trial does not meet the criterion in pi’s post because patient eligibility for the trial was based on an assay rather than on clinical response to a drug during a run-in period.